ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 148 filers reported holding ARCUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,545 | -9.4% | 9,334 | +2.5% | 0.00% | – |
| Q2 2023 | $184,902 | -36.9% | 9,104 | -43.4% | 0.00% | – |
| Q1 2023 | $293,153 | +14.6% | 16,072 | +29.9% | 0.00% | – |
| Q4 2022 | $255,790 | -25.9% | 12,369 | -6.3% | 0.00% | -100.0% |
| Q3 2022 | $345,000 | +38.0% | 13,197 | +33.5% | 0.00% | – |
| Q2 2022 | $250,000 | -59.4% | 9,882 | -49.5% | 0.00% | -100.0% |
| Q1 2022 | $616,000 | -24.8% | 19,550 | -3.5% | 0.00% | 0.0% |
| Q4 2021 | $819,000 | – | 20,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |